Ghias Babar has filed 4 insider transactions across 1 company since July 2025.
Most recent transaction: a grant/award of 121700 shares of BIOCRYST PHARMACEUTICALS INC ($BCRX) on December 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 17, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Ghias Babar | Chief Financial Officer | A | Common Stock | 121700 | $0.00 | 268,700.0000 | 219,885,000 | 82.79% | 0.06% |
| Dec. 17, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Ghias Babar | Chief Financial Officer | A | Emp. Stock Option (Right to Buy) | 355050 | $0.00 | 355,050.0000 | 219,885,000 | 9999.99% | 0.16% |
| July 24, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Ghias Babar | CFO & Head of Corp Development | A | Common Stock | 147000 | $0.00 | 147,000.0000 | 206,696,000 | 9999.99% | 0.07% |
| July 24, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Ghias Babar | CFO & Head of Corp Development | A | Emp. Stock Option (Right to Buy) | 305000 | $0.00 | 305,000.0000 | 206,696,000 | 9999.99% | 0.15% |